drugset / Trial / NCT00583947
A Safety and Tolerability Study of Arformoterol Tartrate Inhalation Solution in Pediatric Subjects
RandomizedCrossoverTriple-blindTreatment
Summary
To determine the safety and tolerability of Arformoterol Tartrate in children with asthma
Timeline
- Start
- 2008-01
- Primary completion
- 2008-12
- Completion
- 2008-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Arformoterol | Small molecule | 7.5 ug | Inhaled |
| Subject | Arformoterol | Small molecule | 15 ug | Inhaled |
| Subject | Levalbuterol | Other / unclassified | 0.63 mg | Inhaled |